Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Valentine

Showing results (471-480 of 574) with videos related to

Pageof 58
Sort By:
Journal of Neurochemistry|September 2, 2006
Protean agonism of the lysophosphatidic acid receptor-1 with Ki16425 reduces nerve growth factor-induced neurite outgrowth in pheochromocytoma 12 cellsNoreen A Moughal, Catherine M Waters, William J Valentine, et al.
Current Medical Research and Opinion|August 25, 2004
Validation of the CORE Diabetes Model against epidemiological and clinical studiesAndrew J Palmer, Stéphane Roze, William J Valentine, et al.
Current Medical Research and Opinion|August 25, 2004
Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetesAndrew J Palmer, Stéphane Roze, Morten Lammert, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|June 26, 2012
A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element productsVincent W Vanek, Peggy Borum, Alan Buchman, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 2, 2018
DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal-Bolus Regimens for Type 2 Diabetes in the UKRichard F Pollock, William J Valentine, Steven P Marso, et al.
BMC Pregnancy and Childbirth|February 15, 2017
Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocolSusan E Carlson, Byron J Gajewski, Christina J Valentine, et al.
Analytical Chemistry|June 15, 2006
An IMS-IMS analogue of MS-MSStormy L Koeniger, Samuel I Merenbloom, Stephen J Valentine, et al.
American Journal of Surgery|December 1, 1986
Is external carotid endarterectomy a durable procedure?D F Fisher, R J Valentine, C B Patterson, et al.
The Journal of Endocrinology|September 10, 2025
CL316,243 and skeletal muscle metabolism: role of sex and estrogen receptor betaAlan Maloney, Jinseok Lee, Eric D Queathem, et al.
Diabetes Research and Clinical Practice|May 21, 2015
Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UKW J Valentine, B H Curtis, R F Pollock, et al.
Pageof 58

Showing results (471-480 of 574) with videos related to

Sort By:
Pageof 58
Journal of Neurochemistry|September 2, 2006
Protean agonism of the lysophosphatidic acid receptor-1 with Ki16425 reduces nerve growth factor-induced neurite outgrowth in pheochromocytoma 12 cellsNoreen A Moughal, Catherine M Waters, William J Valentine, et al.
Current Medical Research and Opinion|August 25, 2004
Validation of the CORE Diabetes Model against epidemiological and clinical studiesAndrew J Palmer, Stéphane Roze, William J Valentine, et al.
Current Medical Research and Opinion|August 25, 2004
Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetesAndrew J Palmer, Stéphane Roze, Morten Lammert, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|June 26, 2012
A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element productsVincent W Vanek, Peggy Borum, Alan Buchman, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 2, 2018
DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal-Bolus Regimens for Type 2 Diabetes in the UKRichard F Pollock, William J Valentine, Steven P Marso, et al.
BMC Pregnancy and Childbirth|February 15, 2017
Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocolSusan E Carlson, Byron J Gajewski, Christina J Valentine, et al.
Analytical Chemistry|June 15, 2006
An IMS-IMS analogue of MS-MSStormy L Koeniger, Samuel I Merenbloom, Stephen J Valentine, et al.
American Journal of Surgery|December 1, 1986
Is external carotid endarterectomy a durable procedure?D F Fisher, R J Valentine, C B Patterson, et al.
The Journal of Endocrinology|September 10, 2025
CL316,243 and skeletal muscle metabolism: role of sex and estrogen receptor betaAlan Maloney, Jinseok Lee, Eric D Queathem, et al.
Diabetes Research and Clinical Practice|May 21, 2015
Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UKW J Valentine, B H Curtis, R F Pollock, et al.
Pageof 58